Invesco Ltd. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$2,079,000
+0.8%
17,561
+0.5%
0.00%0.0%
Q4 2020$2,063,000
-63.4%
17,470
-65.6%
0.00%
-50.0%
Q3 2020$5,639,000
+12.2%
50,740
+3.1%
0.00%0.0%
Q2 2020$5,027,000
+27.2%
49,198
+34.3%
0.00%0.0%
Q1 2020$3,953,000
-19.4%
36,621
-13.1%
0.00%0.0%
Q4 2019$4,905,000
+12.9%
42,143
+11.1%
0.00%
+100.0%
Q3 2019$4,344,000
+6.5%
37,947
-11.3%
0.00%0.0%
Q2 2019$4,078,000
+4.6%
42,789
+0.1%
0.00%0.0%
Q1 2019$3,899,000
+14.3%
42,727
-4.9%
0.00%0.0%
Q4 2018$3,410,000
-9.7%
44,923
-4.9%
0.00%0.0%
Q3 2018$3,778,000
-25.0%
47,228
-6.9%
0.00%
-50.0%
Q2 2018$5,037,000
-76.7%
50,712
-81.0%
0.00%
-75.0%
Q1 2018$21,643,000
-77.2%
267,201
-77.8%
0.01%
-76.5%
Q4 2017$94,853,000
-23.3%
1,204,179
-10.2%
0.03%
-26.1%
Q3 2017$123,694,0001,340,5560.05%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2017
NameSharesValueWeighting ↓
Maso Capital Partners Ltd 143,300$11,464,00011.16%
Hillhouse Capital Management 2,751,200$220,096,0005.88%
York Capital Management Global Advisors, LLC 1,167,643$93,411,0002.95%
Kite Lake Capital Management (UK) LLP 152,836$12,227,0002.53%
RUDMAN ERROL M 80,000$6,400,0002.39%
Dalton Investments, Inc. 54,551$4,364,0002.04%
Greenwoods Asset Management Ltd 245,000$19,600,0001.91%
Point72 Hong Kong Ltd 47,296$3,784,0001.29%
Temasek Holdings (Private) Ltd 990,000$79,200,0000.46%
Kassirer Asset Management Corp 6,000$480,0000.32%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders